Chronic plaque psoriasis is an immune-mediated inflammatory skin disease that is strongly
associated with the clinical features of the metabolic syndrome (MetS), including abdominal …

Psoriasis is an inflammatory immune-mediated disease that affects the skin and has
pathogenic effects with systemic impact. The relationship between psoriasis and …

Psoriasis is a chronic autoinflammatory skin disease associated with multiple comorbidities,
with a prevalence ranging from 2 to 3% in the general population. Decades of preclinical …

Psoriasis may be associated with dyslipidaemia, a known risk factor for cardiovascular
disease. This systematic review aims to synthesize evidence for the association between …

Heart failure with a preserved ejection fraction (HFpEF) and heart failure with a reduced
ejection fraction (HFrEF) have distinctive pathophysiologies, and thus, therapeutic …

HMG-CoA reductase inhibitors, or statins, are potent plasma LDL-cholesterol (LDL-c)
lowering agents. Since the introduction of the first statin, lovastatin, in 1987, accumulating …

Psoriasis is a chronic inflammatory skin condition, with genetic, epigenetic, environmental,
and lifestyle factors contributing to its onset and recurrence. Severe psoriasis has a great …

Psoriasis is a chronic, systematic, inflammatory disease in which multiple metabolic and
immunologic disturbances lead to lipid abnormalities, impaired glucose tolerance, metabolic …

Results Of 279 records identified, there were 5 eligible RCTs, with a total of 223 patients,
including 128 patients who received a statin (atorvastatin or simvastatin). The improvement …

Objective To summarize the current state of evidence for combination topical and systemic
therapies for mild to severe psoriasis. Data Sources We performed a systematic search for …